Analysis  ||| S:0 E:9 ||| NN
of  ||| S:9 E:12 ||| IN
the  ||| S:12 E:16 ||| DT
mucosal  ||| S:16 E:24 ||| JJ
immune  ||| S:24 E:31 ||| JJ
responses  ||| S:31 E:41 ||| NNS
induced  ||| S:41 E:49 ||| VBN
by  ||| S:49 E:52 ||| IN
single  ||| S:52 E:59 ||| JJ
and  ||| S:59 E:63 ||| CC
trickle  ||| S:63 E:71 ||| JJ
infections  ||| S:71 E:82 ||| NNS
with  ||| S:82 E:87 ||| IN
the  ||| S:87 E:91 ||| DT
bovine  ||| S:91 E:98 ||| FW
abomasal  ||| S:98 E:107 ||| FW
nematode  ||| S:107 E:116 ||| FW
Ostertagia  ||| S:116 E:127 ||| FW
ostertagi  ||| S:127 E:137 ||| FW
The  ||| S:137 E:141 ||| DT
purpose  ||| S:141 E:149 ||| NN
of  ||| S:149 E:152 ||| IN
this  ||| S:152 E:157 ||| DT
study  ||| S:157 E:163 ||| NN
was  ||| S:163 E:167 ||| VBD
to  ||| S:167 E:170 ||| TO
provide  ||| S:170 E:178 ||| VB
more  ||| S:178 E:183 ||| JJR
information  ||| S:183 E:195 ||| NN
on  ||| S:195 E:198 ||| IN
the  ||| S:198 E:202 ||| DT
kinetics  ||| S:202 E:211 ||| NN
of  ||| S:211 E:214 ||| IN
the  ||| S:214 E:218 ||| DT
immunological  ||| S:218 E:232 ||| JJ
changes  ||| S:232 E:240 ||| NNS
occurring  ||| S:240 E:250 ||| VBG
in  ||| S:250 E:253 ||| IN
the  ||| S:253 E:257 ||| DT
abomasal  ||| S:257 E:266 ||| JJ
mucosa  ||| S:266 E:273 ||| NN
after  ||| S:273 E:279 ||| IN
single  ||| S:279 E:286 ||| JJ
and  ||| S:286 E:290 ||| CC
trickle  ||| S:290 E:298 ||| JJ
infections  ||| S:298 E:309 ||| NNS
with  ||| S:309 E:314 ||| IN
the  ||| S:314 E:318 ||| DT
bovine  ||| S:318 E:325 ||| FW
parasite  ||| S:325 E:334 ||| FW
Ostertagia  ||| S:334 E:345 ||| FW
ostertagi ||| S:345 E:354 ||| FW
.  ||| S:354 E:356 ||| .
The  ||| S:356 E:360 ||| DT
time  ||| S:360 E:365 ||| NN
course  ||| S:365 E:372 ||| NN
analysis  ||| S:372 E:381 ||| NN
of  ||| S:381 E:384 ||| IN
gene  ||| S:384 E:389 ||| NN
expression  ||| S:389 E:400 ||| NN
revealed  ||| S:400 E:409 ||| VBD
that  ||| S:409 E:414 ||| IN
the  ||| S:414 E:418 ||| DT
major  ||| S:418 E:424 ||| JJ
changes  ||| S:424 E:432 ||| NNS
coincided  ||| S:432 E:442 ||| VBD
with  ||| S:442 E:447 ||| IN
the  ||| S:447 E:451 ||| DT
emergence  ||| S:451 E:461 ||| NN
of  ||| S:461 E:464 ||| IN
adult  ||| S:464 E:470 ||| NN
worms  ||| S:470 E:476 ||| NNS
from  ||| S:476 E:481 ||| IN
the  ||| S:481 E:485 ||| DT
gastric  ||| S:485 E:493 ||| JJ
glands ||| S:493 E:499 ||| NN
.  ||| S:499 E:501 ||| .
These  ||| S:501 E:507 ||| DT
changes  ||| S:507 E:515 ||| NNS
consisted  ||| S:515 E:525 ||| VBD
of  ||| S:525 E:528 ||| IN
a  ||| S:528 E:530 ||| DT
simultaneous  ||| S:530 E:543 ||| JJ
upregulation  ||| S:543 E:556 ||| NN
of  ||| S:556 E:559 ||| IN
Th1-  ||| S:559 E:564 ||| NNP
and  ||| S:564 E:568 ||| CC
Th2-type  ||| S:568 E:577 ||| CD
cytokines ||| S:577 E:586 ||| NNS
.  ||| S:586 E:588 ||| .
In  ||| S:588 E:591 ||| IN
addition ||| S:591 E:599 ||| NN
,  ||| S:599 E:601 ||| ,
a  ||| S:601 E:603 ||| DT
single  ||| S:603 E:610 ||| JJ
O. ostertagi  ||| S:610 E:623 ||| CD
infection  ||| S:623 E:633 ||| NN
elicited  ||| S:633 E:642 ||| VBD
an  ||| S:642 E:645 ||| DT
upregulation  ||| S:645 E:658 ||| NN
of  ||| S:658 E:661 ||| IN
the  ||| S:661 E:665 ||| DT
epithelial-derived  ||| S:665 E:684 ||| JJ
cytokine  ||| S:684 E:693 ||| JJ
IL33 ||| S:693 E:697 ||| NN
,  ||| S:697 E:699 ||| ,
while  ||| S:699 E:705 ||| IN
TSLP  ||| S:705 E:710 ||| NNP
expression  ||| S:710 E:721 ||| NN
levels  ||| S:721 E:728 ||| NNS
were  ||| S:728 E:733 ||| VBD
not  ||| S:733 E:737 ||| RB
impacted ||| S:737 E:745 ||| VBN
.  ||| S:745 E:747 ||| .
Apart  ||| S:747 E:753 ||| RB
from  ||| S:753 E:758 ||| IN
the  ||| S:758 E:762 ||| DT
massive  ||| S:762 E:770 ||| JJ
increase  ||| S:770 E:779 ||| NN
in  ||| S:779 E:782 ||| IN
inflammatory  ||| S:782 E:795 ||| JJ
cytokines  ||| S:795 E:805 ||| JJ
IL6 ||| S:805 E:808 ||| NN
,  ||| S:808 E:810 ||| ,
IL17  ||| S:810 E:815 ||| NNP
and  ||| S:815 E:819 ||| CC
IL21 ||| S:819 E:823 ||| NNP
,  ||| S:823 E:825 ||| ,
O. ostertagi  ||| S:825 E:838 ||| CD
infection  ||| S:838 E:848 ||| NN
also  ||| S:848 E:853 ||| RB
elicited  ||| S:853 E:862 ||| VB
an  ||| S:862 E:865 ||| DT
upregulation  ||| S:865 E:878 ||| NN
of  ||| S:878 E:881 ||| IN
the  ||| S:881 E:885 ||| DT
immunosuppressors  ||| S:885 E:903 ||| JJ
TGFB ||| S:903 E:907 ||| NNP
,  ||| S:907 E:909 ||| ,
IL10  ||| S:909 E:914 ||| NNP
and  ||| S:914 E:918 ||| CC
ARG1 ||| S:918 E:922 ||| NNP
,  ||| S:922 E:924 ||| ,
as  ||| S:924 E:927 ||| RB
well  ||| S:927 E:932 ||| RB
as  ||| S:932 E:935 ||| IN
NK  ||| S:935 E:938 ||| NNP
and  ||| S:938 E:942 ||| CC
γδ-T  ||| S:942 E:947 ||| JJ
cell  ||| S:947 E:952 ||| NN
markers ||| S:952 E:959 ||| NN
.  ||| S:959 E:961 ||| .
Furthermore ||| S:961 E:972 ||| RB
,  ||| S:972 E:974 ||| ,
the  ||| S:974 E:978 ||| DT
cytotoxic  ||| S:978 E:988 ||| JJ
factors  ||| S:988 E:996 ||| NNS
granulysin ||| S:996 E:1006 ||| NN
,  ||| S:1006 E:1008 ||| ,
perforin  ||| S:1008 E:1017 ||| NN
and  ||| S:1017 E:1021 ||| CC
granzyme  ||| S:1021 E:1030 ||| JJ
B  ||| S:1030 E:1032 ||| NNP
were  ||| S:1032 E:1037 ||| VBD
upregulated  ||| S:1037 E:1049 ||| VBN
following  ||| S:1049 E:1059 ||| VBG
an  ||| S:1059 E:1062 ||| DT
O. ostertagi  ||| S:1062 E:1075 ||| JJ
infection ||| S:1075 E:1084 ||| NN
.  ||| S:1084 E:1086 ||| .
Analysis  ||| S:1086 E:1095 ||| NN
of  ||| S:1095 E:1098 ||| IN
cytokine  ||| S:1098 E:1107 ||| JJ
transcript  ||| S:1107 E:1118 ||| NN
levels  ||| S:1118 E:1125 ||| NNS
in  ||| S:1125 E:1128 ||| IN
animals  ||| S:1128 E:1136 ||| NNS
receiving  ||| S:1136 E:1146 ||| VBG
trickle  ||| S:1146 E:1154 ||| JJ
infections  ||| S:1154 E:1165 ||| NNS
for  ||| S:1165 E:1169 ||| IN
60 days  ||| S:1169 E:1177 ||| NNP
showed  ||| S:1177 E:1184 ||| VBD
a  ||| S:1184 E:1186 ||| DT
similar  ||| S:1186 E:1194 ||| JJ
trend  ||| S:1194 E:1200 ||| NN
as  ||| S:1200 E:1203 ||| RB
observed  ||| S:1203 E:1212 ||| VBD
following  ||| S:1212 E:1222 ||| VBG
a  ||| S:1222 E:1224 ||| DT
single  ||| S:1224 E:1231 ||| JJ
infection  ||| S:1231 E:1241 ||| NN
except  ||| S:1241 E:1248 ||| IN
for  ||| S:1248 E:1252 ||| IN
IL33 ||| S:1252 E:1256 ||| NNP
,  ||| S:1256 E:1258 ||| ,
IL6 ||| S:1258 E:1261 ||| NNP
,  ||| S:1261 E:1263 ||| ,
GATA-3 ||| S:1263 E:1269 ||| NNP
,  ||| S:1269 E:1271 ||| ,
TBX21  ||| S:1271 E:1277 ||| NNP
and  ||| S:1277 E:1281 ||| CC
NCR1 ||| S:1281 E:1285 ||| NNP
,  ||| S:1285 E:1287 ||| ,
which  ||| S:1287 E:1293 ||| WDT
were  ||| S:1293 E:1298 ||| VBD
no  ||| S:1298 E:1301 ||| DT
longer  ||| S:1301 E:1308 ||| JJR
upregulated  ||| S:1308 E:1320 ||| NN
after  ||| S:1320 E:1326 ||| IN
trickle  ||| S:1326 E:1334 ||| JJ
infections ||| S:1334 E:1344 ||| NNS
.  ||| S:1344 E:1346 ||| .
Finally ||| S:1346 E:1353 ||| RB
,  ||| S:1353 E:1355 ||| ,
the  ||| S:1355 E:1359 ||| DT
long  ||| S:1359 E:1364 ||| JJ
trickle  ||| S:1364 E:1372 ||| NN
infections  ||| S:1372 E:1383 ||| NNS
were  ||| S:1383 E:1388 ||| VBD
associated  ||| S:1388 E:1399 ||| VBN
with  ||| S:1399 E:1404 ||| IN
mucosal  ||| S:1404 E:1412 ||| JJ
eosinophilia  ||| S:1412 E:1425 ||| NN
and  ||| S:1425 E:1429 ||| CC
mastocytosis ||| S:1429 E:1441 ||| NN
.  ||| S:1441 E:1443 ||| .
